ArticleNature communications2024

Influence of microbiota-associated metabolic reprogramming on clinical outcome in patients with melanoma from the randomized adjuvant dendritic cell-based MIND-DC trial.

Carolina Alves Costa Silva et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.